Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hemorrheology (also spelled haemorheology or known as blood rheology) is the scientific discipline studying the flow properties and deformation of blood and its cellular and plasma components, including erythrocytes (red blood cells), leukocytes (white blood cells), platelets, and plasma[1][2][3][4][5][6][7]. The field analyzes how these biophysical properties affect circulation, tissue perfusion, and are implicated in various disease states, but it is not a drug target, receptor, enzyme, or macromolecule. Hemorheology addresses concepts such as blood viscosity, cellular deformability, aggregation, and plasma protein interactions, all of which impact vascular resistance, oxygen delivery, and hemodynamic health[1][4][5]. Any listing of "hemorheology" as a target molecule or receptor is a category error.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hemorrheology.